Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q1- Text added to 2023 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Good
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Good
|
New words:
AACR, attached, award, CBR, cetuximab, combo, compelling, copy, double, driven, EGFR, entirety, Exhibit, Fifteen, Genentach, helical, mono, osimertinib, Peter, PR, PRs, Rahmer, retention, stable, text, unconfirmed, withholding
Removed:
adjustment, Affordable, avoid, beginning, bioresearch, brand, branded, broadening, Children, complicating, conceal, concealing, defer, defraud, domestic, emergency, enrolled, executing, expanded, false, falsifying, family, FCA, gave, govern, heightened, HITECH, imaging, induce, Inspector, intent, interactive, kind, knowingly, largely, lowering, minimum, negotiated, passed, permission, Portability, presenting, qui, reimbursable, Relief, remote, remuneration, resume, reward, routine, scheme, statute, step, Sunshine, tam, Taxpayer, teaching, transmission, transparency, undergoing, unfair, whistleblower
Valuein 2023 Q1 filing- Value in 2023 Q2 filing
Original filings
Filing view